All data from the experiment. by Kazufumi Hisamoto (21416905)

Subjects:

Cardiopulmonary variables at peak under the HYPO, NOR, and HYPER conditions. by Kazufumi Hisamoto (21416905)

Subjects:

Cardiopulmonary variables at rest and peak under the NOR condition. by Kazufumi Hisamoto (21416905)

Subjects:

The protocol of the maximal cycle-ergometer test. by Kazufumi Hisamoto (21416905)

Subjects:

Comparison of the changes in HR (A), SBP (B), DP (C), and SpO2 (D) during maximal exercise test among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Subjects:

Comparison of W_max (A), the changes in V_E (B), and W_VT (C) among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Subjects:

Determination of the ventilatory threshold (VT) point. by Kazufumi Hisamoto (21416905)

Subjects:

Comparison of SpO₂ (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Subjects:

Splenocytes from Tcj2 mRNA LNP—Immunized mice decrease <i>T</i>. <i>cruzi</i> infection <i>in vitro</i>. by Leroy Versteeg (4248760)

Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Patient flowchart. by Anna D. Ware (19688153)

Subjects:

Data Sheet 1_Statistics and behavior of clinically significant extra-pulmonary vein atrial fibrillation sources: machine-learning-enhanced electrographic flow mapping in persistent... by Peter Ruppersberg (22123543)

“…Here, we present how our EGF Model—trained on procedural outcomes from 199 fully anonymized retrospective patient datasets—identifies clinically significant sources of AF and how this machine learning–driven hyperparameter optimization underlies its clinical effectiveness. …”

RTA408 significantly reduces RGCs loss. by Hongmei Qian (538647)

Subjects:

The clinical characteristic of patients. by Hai-bo Ai (20790405)

“…When the rate was between 18% and 59%, medical costs decreased as the rate increased, and when the rate was < 18% or ≥  59%, medical costs did not decrease as the rate increased.…”

Fuchioka dataset 251021. by Yusuke Fuchioka (22806178)

Subjects:

An exemplary case one year after open wedge high tibial osteotomy (OWHTO) for right knee osteoarthritis. by Yusuke Fuchioka (22806178)

Subjects:

Patellar 3D-MRI before and after OWHTO in all cases. by Yusuke Fuchioka (22806178)

Subjects:

Quantification of cartilage thickness in all cases. by Yusuke Fuchioka (22806178)

Subjects:

Detailed analysis of the patellofemoral interactions after OWHTO in Knee 01. by Yusuke Fuchioka (22806178)

Subjects: